Anissimov Y - Search Results

1

Smart Nanotheranostics Responsive to Pathological Stimuli.

Parodi A, Rudzinska M, Leporatti S, Anissimov Y, Zamyatnin AA Jr. Parodi A, et al. Among authors: anissimov y. Front Bioeng Biotechnol. 2020 May 25;8:503. doi: 10.3389/fbioe.2020.00503. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32523946 Free PMC article. Review.

2

Modeling drug transport within the viable skin - a review.

Calcutt JJ, Roberts MS, Anissimov YG. Calcutt JJ, et al. Among authors: anissimov yg. Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):105-119. doi: 10.1080/17425255.2020.1832081. Epub 2020 Dec 3. Expert Opin Drug Metab Toxicol. 2021. PMID: 33017199 Review.

3

Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Behtaj S, Öchsner A, Anissimov YG, Rybachuk M. Behtaj S, et al. Tissue Eng Regen Med. 2020 Jun;17(3):253-269. doi: 10.1007/s13770-020-00254-8. Epub 2020 May 10. Tissue Eng Regen Med. 2020. PMID: 32390117 Free PMC article. Review.

4

Predicting viable skin concentration: Diffusional and convective drug transport.

Calcutt JJ, Anissimov YG. Calcutt JJ, et al. Among authors: anissimov yg. J Pharm Sci. 2021 Jul;110(7):2823-2832. doi: 10.1016/j.xphs.2021.03.012. Epub 2021 Mar 21. J Pharm Sci. 2021. PMID: 33762180

5

Modelling dermal drug distribution after topical application in human.

Anissimov YG, Roberts MS. Anissimov YG, et al. Pharm Res. 2011 Sep;28(9):2119-29. doi: 10.1007/s11095-011-0437-2. Epub 2011 Apr 27. Pharm Res. 2011. PMID: 21523512

6

Modeling the human skin barrier--towards a better understanding of dermal absorption.

Jepps OG, Dancik Y, Anissimov YG, Roberts MS. Jepps OG, et al. Among authors: anissimov yg. Adv Drug Deliv Rev. 2013 Feb;65(2):152-68. doi: 10.1016/j.addr.2012.04.003. Epub 2012 Apr 14. Adv Drug Deliv Rev. 2013. PMID: 22525516 Free article. Review.

7

Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes.

Anissimov YG, Jepps OG, Dancik Y, Roberts MS. Anissimov YG, et al. Adv Drug Deliv Rev. 2013 Feb;65(2):169-90. doi: 10.1016/j.addr.2012.04.009. Epub 2012 May 7. Adv Drug Deliv Rev. 2013. PMID: 22575500 Review.

8

Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.

Liu X, Yousef S, Anissimov YG, van der Hoek J, Tsakalozou E, Ni Z, Grice JE, Roberts MS. Liu X, et al. Eur J Pharm Biopharm. 2020 Apr;149:30-44. doi: 10.1016/j.ejpb.2020.01.018. Epub 2020 Feb 1. Eur J Pharm Biopharm. 2020. PMID: 32018051

9

Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models.

Liu X, Anissimov YG, Grice JE, Cheruvu HS, Ghosh P, Raney SG, Maibach HI, Roberts MS. Liu X, et al. Among authors: anissimov yg. J Control Release. 2021 Jun 10;334:37-51. doi: 10.1016/j.jconrel.2021.04.010. Epub 2021 Apr 20. J Control Release. 2021. PMID: 33857564

10

Predicting Viable Skin Concentration: Modelling the Subpapillary Plexus.

Calcutt JJ, Roberts MS, Anissimov YG. Calcutt JJ, et al. Among authors: anissimov yg. Pharm Res. 2022 Apr;39(4):783-793. doi: 10.1007/s11095-022-03215-z. Epub 2022 Mar 9. Pharm Res. 2022. PMID: 35266087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters